A Phase 4 Study to Evaluate Adrenal Function in Hypogonadal Men Treated With JATENZO® for 12 Months
Clinical trial NCT06385509 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06385509
- Sponsor
- Tolmar Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-10
- Primary completion
- 2025-11-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.